Rontalizumab phase iii trials - Table: List of monoclonal antibodies, including the
Lupus Clinical Trials News . March 30, New Phase III Trial Testing Lupuzor™ for Lupus. Rontalizumab May Help Patients with Lupus Low Interferon Signature.
Biologics in systemic lupus erythematosus: Current options and future perspectives. rontalizumab (anti-interferon combined results from two phase III trials
Clinical trials The European Union Prior exposure to anifrolumab or rontalizumab e) (Phase III) No : E. 7. 4: Therapeutic use (Phase IV) No : E. 8 Design of the
A phase III trial is underway, The results seem promising but phase III trials are needed. Rontalizumab IFNα blocker Phase II
Advances in drug therapy for systemic lupus erythematosus. Rontalizumab inhibits IFN- They are currently in phase III trials.
. . (does so badly in clinical trials) moved forward to phase III clinical trials and rontalizumab was in phase II and III trials for the treatment